利钠肽家族中的 B 型利钠肽（BNP）和 N 末端 B 型利钠肽原（NT-proBNP）是目前在心衰诊疗中应用最广泛的生物标志物，有助于急慢性心衰的诊断和鉴别诊断、危险分层、疗效监测及预后评估。 同是心衰标志物，BNP 与 NT-proBNP 有什么联系和区别呢？ 01 BNP＆NT-proBNP ...

B-type natriuretic peptide (BNP) and its precursor, N-terminal pro-brain BNP (NT-proBNP) have been extensively studied for their predictive value in patients with heart failure. A systematic ...

The inactive N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) has been linked to ventricular dysfunction in the general population, and is predictive of cardiac events. Corteville ...

BNP是一种心脏分泌的肽类激素，其主要使命是调节体内的水盐平衡并抑制心脏的压力。然而，仅凭BNP水平的高低来判断一个人是否患有心衰，可能会导致错误的诊断。许多研究，包括2019年的《传感器》期刊，指出BNP水平的变化可以受多种因素的影响，如年龄、体重、肾功能等。因此，临床医生不能仅只依赖BNP数据，必须结合其他临床指标全面评估患者的心脏健康状况。

为探究黑人和白人个体利钠肽（NP）系统对运动和 β- 阻滞剂反应的差异，美国阿拉巴马大学伯明翰分校研究人员开展相关临床试验，发现运动后白人 NT-proBNP 升幅更大，这对理解种族间心血管和代谢健康差异意义重大，值得科研人员一读。 自我认定为白人和黑人 ...

An assay measuring N-terminal pro-BNP, or NT-proBNP, is more sensitive to detect heart failure and used in many institutions. The levels of BNP and NT-proBNP are essentially the same in normal ...

Circulating concentrations of B-type natriuretic peptide (BNP) and the N-terminal fragment (NT) of its prohormone (proBNP) are related to cardiac function and have emerged as clinically useful ...

Diagnostic thresholds of N-terminal prohormone of brain natriuretic peptide (NT-proBNP) for heart failure with preserved ejection fraction (HFpEF) in ambulatory patients with chronic ...

A newer assay measuring NT-terminal pro-BNP (NT-proBNP) is more sensitive to detect heart failure and used in many institutions. The levels of BNP and NT-proBNP are essentially the same in normal ...

This has previously been speculated, as elevated concentrations of BNP or N-terminal pro brain natriuretic peptide (NT-proBNP) in cardiovascular patients were found to be related to immune reactions ...

Creative Diagnostics announced the launch of its new range of BNP and NT-proBNP antibodies for raw material and research applications. The natriuretic peptides, including proBNP (pro-brain ...

Combination therapy with oral or inhaled treprostinil may benefit patients with pulmonary arterial hypertension and cardiovascular comorbidities.